Spyre Therapeutics, Inc. SYRE Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Spyre Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Spyre Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Spyre Therapeutics, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Spyre Therapeutics, Inc.'s asset turnover?
- Spyre Therapeutics, Inc. (SYRE) reported asset turnover of 0× in Q4 2025.
- What does asset turnover mean?
- How many sales dollars the company generates from each dollar of assets.
- How do you interpret asset turnover?
- Higher turnover means a more sales-efficient asset base. Low-margin businesses (retail, distribution) compete on high turnover; high-margin ones (software, luxury) on margin.
- How does asset turnover compare across companies?
- Compare within an industry — turnover differences across sectors reflect business models, not performance.